Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Plo

Showing results (81-90 of 124) with videos related to

Pageof 13
Sort By:
Blood|January 4, 2019
Disrupted filamin A/α<sub>IIb</sub>β<sub>3</sub> interaction induces macrothrombocytopenia by increasing RhoA activityAlessandro Donada, Nathalie Balayn, Dominika Sliwa, et al.
British Journal of Haematology|March 31, 2022
An inherited gain-of-function risk allele in EPOR predisposes to familial JAK2<sup>V617F</sup> myeloproliferative neoplasmsGraciela Rabadan Moraes, Florence Pasquier, Christophe Marzac, et al.
Journal of Thrombosis and Haemostasis : JTH|September 11, 2024
Impaired fibrinolysis in JAK2V617F-related myeloproliferative neoplasmsMarie-Charlotte Bourrienne, Stéphane Loyau, Dorothée Faille, et al.
Blood|December 31, 2016
An incomplete trafficking defect to the cell-surface leads to paradoxical thrombocytosis for human and murine MPL P106LFabrizia Favale, Kahia Messaoudi, Leila N Varghese, et al.
Blood Cancer Discovery|March 15, 2022
In Vivo Monitoring of Polycythemia Vera Development Reveals Carbonic Anhydrase 1 as a Potent Therapeutic TargetShohei Murakami, Vilma Barroca, Leïla Perié, et al.
Blood|June 11, 2021
Dual role of EZH2 in megakaryocyte differentiationStefania Mazzi, Philippe Dessen, Mathieu Vieira, et al.
Blood|January 9, 2014
Germ-line JAK2 mutations in the kinase domain are responsible for hereditary thrombocytosis and are resistant to JAK2 and HSP90 inhibitorsCaroline Marty, Cécile Saint-Martin, Christian Pecquet, et al.
Molecular Cell|December 2, 2019
Immunosuppression by Mutated Calreticulin Released from Malignant CellsPeng Liu, Liwei Zhao, Friedemann Loos, et al.
Blood|July 1, 2009
Analysis of the ten-eleven translocation 2 (TET2) gene in familial myeloproliferative neoplasmsCécile Saint-Martin, Gwendoline Leroy, François Delhommeau, et al.
Stem Cells (Dayton, Ohio)|April 12, 2014
TET2 deficiency inhibits mesoderm and hematopoietic differentiation in human embryonic stem cellsThierry Langlois, Barbara da Costa Reis Monte-Mor, Gaëlle Lenglet, et al.
Pageof 13

Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
Blood|January 4, 2019
Disrupted filamin A/α<sub>IIb</sub>β<sub>3</sub> interaction induces macrothrombocytopenia by increasing RhoA activityAlessandro Donada, Nathalie Balayn, Dominika Sliwa, et al.
British Journal of Haematology|March 31, 2022
An inherited gain-of-function risk allele in EPOR predisposes to familial JAK2<sup>V617F</sup> myeloproliferative neoplasmsGraciela Rabadan Moraes, Florence Pasquier, Christophe Marzac, et al.
Journal of Thrombosis and Haemostasis : JTH|September 11, 2024
Impaired fibrinolysis in JAK2V617F-related myeloproliferative neoplasmsMarie-Charlotte Bourrienne, Stéphane Loyau, Dorothée Faille, et al.
Blood|December 31, 2016
An incomplete trafficking defect to the cell-surface leads to paradoxical thrombocytosis for human and murine MPL P106LFabrizia Favale, Kahia Messaoudi, Leila N Varghese, et al.
Blood Cancer Discovery|March 15, 2022
In Vivo Monitoring of Polycythemia Vera Development Reveals Carbonic Anhydrase 1 as a Potent Therapeutic TargetShohei Murakami, Vilma Barroca, Leïla Perié, et al.
Blood|June 11, 2021
Dual role of EZH2 in megakaryocyte differentiationStefania Mazzi, Philippe Dessen, Mathieu Vieira, et al.
Blood|January 9, 2014
Germ-line JAK2 mutations in the kinase domain are responsible for hereditary thrombocytosis and are resistant to JAK2 and HSP90 inhibitorsCaroline Marty, Cécile Saint-Martin, Christian Pecquet, et al.
Molecular Cell|December 2, 2019
Immunosuppression by Mutated Calreticulin Released from Malignant CellsPeng Liu, Liwei Zhao, Friedemann Loos, et al.
Blood|July 1, 2009
Analysis of the ten-eleven translocation 2 (TET2) gene in familial myeloproliferative neoplasmsCécile Saint-Martin, Gwendoline Leroy, François Delhommeau, et al.
Stem Cells (Dayton, Ohio)|April 12, 2014
TET2 deficiency inhibits mesoderm and hematopoietic differentiation in human embryonic stem cellsThierry Langlois, Barbara da Costa Reis Monte-Mor, Gaëlle Lenglet, et al.
Pageof 13